Century Therapeutics

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Century Therapeutics sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting early-phase tilt upper quartile by trial count

Century Therapeutics: 3 sponsored US clinical trials, 1 recruiting.

Century Therapeutics sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Solid Tumor Malignancy, with 1 trials.

Upper-quartile sponsor footprint

Century Therapeutics sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

NCT05768269
ACTIVE NOT RECRUITING Phase 1

A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

NCT06255028
TERMINATED Phase 1

A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

NCT05336409

Phase Distribution

PhaseTrial count
Phase 1 2

Therapeutic Areas

Solid Tumor Malignancy 1
Idiopathic Inflammatory Myopathies 1
Diffuse Cutaneous Systemic Sclerosis 1
Lupus Nephritis 1
Hematological Malignancy 1
Systemic Lupus Erythematosus 1

What is open in the Century Therapeutics pipeline

1 recruiting of 3 indexed (33% open).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Solid Tumor Malignancy (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Century Therapeutics: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Century Therapeutics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share Century Therapeutics10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Century Therapeutics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Century Therapeutics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Century Therapeutics page

3 registered trials is a research-attention snapshot, not an endorsement of Century Therapeutics or any single study.

  • 1 of Century Therapeutics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Solid Tumor Malignancy is the condition Century Therapeutics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Solid Tumor Malignancy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Century Therapeutics pipeline card: 3 registered trials from official public datasets.Report a data error.